These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 18510894)

  • 41. Hepatitis B in the HIV-coinfected patient.
    Benhamou Y
    J Acquir Immune Defic Syndr; 2007 Jul; 45 Suppl 2():S57-65; discussion S66-7. PubMed ID: 17704693
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment of chronic hepatitis B: case selection and duration of therapy.
    Leung N
    J Gastroenterol Hepatol; 2002 Apr; 17(4):409-14. PubMed ID: 11982721
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Advances in treating drug-resistant hepatitis B virus in HIV-infected patients.
    Soriano V; de Mendoza C; Peña JM; Barreiro P
    Expert Opin Pharmacother; 2015 Feb; 16(2):179-86. PubMed ID: 25529507
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Long-term therapy for chronic hepatitis B in HIV co-infected patients].
    Pais R; Benhamou Y
    Gastroenterol Clin Biol; 2010 Sep; 34 Suppl 2():S136-41. PubMed ID: 21095517
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of long-term tenofovir-based combination antiretroviral therapy in HIV-hepatitis B virus coinfection on persistent hepatitis B virus viremia and the role of hepatitis B virus quasispecies diversity.
    Audsley J; Bent SJ; Littlejohn M; Avihingsanon A; Matthews G; Bowden S; Bayliss J; Luciani F; Yuen L; Fairley CK; Locarnini S; Lewin SR; Sasadeusz J
    AIDS; 2016 Jun; 30(10):1597-606. PubMed ID: 26950313
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-term therapy with tenofovir is effective for patients co-infected with human immunodeficiency virus and hepatitis B virus.
    de Vries-Sluijs TE; Reijnders JG; Hansen BE; Zaaijer HL; Prins JM; Pas SD; Schutten M; Hoepelman AI; Richter C; Mulder JW; de Man RA; Janssen HL; van der Ende ME
    Gastroenterology; 2010 Dec; 139(6):1934-41. PubMed ID: 20801123
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hepatitis B virus genotypes and lamivudine resistance mutations in HIV/hepatitis B virus-coinfected patients.
    Ramos B; Núñez M; Martín-Carbonero L; Sheldon J; Rios P; Labarga P; Romero M; Barreiro P; García-Samaniego J; Soriano V
    J Acquir Immune Defic Syndr; 2007 Apr; 44(5):557-61. PubMed ID: 17224847
    [TBL] [Abstract][Full Text] [Related]  

  • 48. HIV-HBV coinfection in Southern Africa and the effect of lamivudine- versus tenofovir-containing cART on HBV outcomes.
    Hamers RL; Zaaijer HL; Wallis CL; Siwale M; Ive P; Botes ME; Sigaloff KC; Hoepelman AI; Stevens WS; Rinke de Wit TF;
    J Acquir Immune Defic Syndr; 2013 Oct; 64(2):174-82. PubMed ID: 23892239
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Influence of HIV infection on response to tenofovir in patients with chronic hepatitis B.
    Plaza Z; Aguilera A; Mena A; Vispo E; Sierra-Enguita R; Tomé S; Pedreira J; Rodriguez C; Barreiro P; del Romero J; Soriano V; Poveda E
    AIDS; 2013 Sep; 27(14):2219-24. PubMed ID: 23669158
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Combination of tenofovir and lamivudine versus tenofovir after lamivudine failure for therapy of hepatitis B in HIV-coinfection.
    Schmutz G; Nelson M; Lutz T; Sheldon J; Bruno R; von Boemmel F; Hoffmann C; Rockstroh J; Stoehr A; Wolf E; Soriano V; Berger F; Berg T; Carlebach A; Schwarze-Zander C; Schürmann D; Jaeger H; Mauss S
    AIDS; 2006 Oct; 20(15):1951-4. PubMed ID: 16988516
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hepatitis B virus and HIV coinfection: results of a survey on treatment practices and recommendations for therapy.
    Gaglio PJ; Sterling R; Daniels E; Tedaldi E;
    Clin Infect Dis; 2007 Sep; 45(5):618-23. PubMed ID: 17682998
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Highly active antiretroviral therapy used to treat concurrent hepatitis B and human immunodeficiency virus infections.
    Nagai K; Hosaka H; Kubo S; Nakamura N; Shinohara M; Nonaka H
    J Gastroenterol; 1999 Apr; 34(2):275-81. PubMed ID: 10213132
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment of chronic hepatitis B in the human immunodeficiency virus-infected patient: present and future.
    Núñez M; Puoti M; Camino N; Soriano V
    Clin Infect Dis; 2003 Dec; 37(12):1678-85. PubMed ID: 14689351
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Complications in treating chronic hepatitis B in patients with HIV.
    Soriano V; Nuñez M; Sheldon J; Ramos B; Garcia-Samaniego J; Martín-Carbonero L; Maida I; Gonzalez-Lahoz J
    Expert Opin Pharmacother; 2005 Dec; 6(16):2831-42. PubMed ID: 16318434
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antiretroviral treatment change among HIV, hepatitis B virus and hepatitis C virus co-infected patients in the Australian HIV Observational Database.
    Petoumenos K; Ringland C;
    HIV Med; 2005 May; 6(3):155-63. PubMed ID: 15876281
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The treatment outcome of chronic HBV infection among HBV/HIV co-infected and HBV mono-infected patients.
    Karić U; Milošević I; Pešić-Pavlović I; Salemović D; Stojković M; Jevtović D
    Int J STD AIDS; 2020 Jan; 31(1):38-45. PubMed ID: 31838949
    [No Abstract]   [Full Text] [Related]  

  • 57. Therapeutic strategies for chronic hepatitis B virus infection in 2008-optimum dosing lamivudine challenged for HIV-1 infected patients.
    van den Berg-Wolf M; Tedaldi EM
    Am J Med; 2009 Aug; 122(8):e11. PubMed ID: 19635261
    [No Abstract]   [Full Text] [Related]  

  • 58. Hepatitis B virus resistance to lamivudine and its clinical implications.
    Liu X; Schinazi RF
    Antivir Chem Chemother; 2002 May; 13(3):143-55. PubMed ID: 12448687
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Case report: management and HBV sequencing in a patient co-infected with HBV and HIV failing tenofovir.
    Mikulska M; Taramasso L; Giacobbe DR; Caligiuri P; Bruzzone B; Di Biagio A; Viscoli C
    J Med Virol; 2012 Sep; 84(9):1340-3. PubMed ID: 22825811
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular analysis of an HBsAg-negative hepatitis B virus mutant selected in a tenofovir-treated HIV-hepatitis B virus co-infected patient.
    Amini-Bavil-Olyaee S; Sheldon J; Lutz T; Trautwein C; Tacke F
    AIDS; 2009 Jan; 23(2):268-72. PubMed ID: 19098499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.